PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Frequently asked questions
What sector does Kalbe Farma Tbk PT ADR (PTKFY) operate in?
Kalbe Farma Tbk PT ADR belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Kalbe Farma Tbk PT ADR (PTKFY) current stock price?
As of the latest data, Kalbe Farma Tbk PT ADR stock price is $7.98, with a previous close of $7.97. Kalbe Farma Tbk PT ADR gained $0.01 in the last trading session, representing a 0.13% increase.
What is Kalbe Farma Tbk PT ADR (PTKFY) current market capitalization?
Kalbe Farma Tbk PT ADR market cap is approximately 1.80 billion.
What is Kalbe Farma Tbk PT ADR (PTKFY) Earnings Per Share (EPS)?
The trailing EPS is $0.89.
What is Kalbe Farma Tbk PT ADR (PTKFY) Price-to-Earnings (P/E) ratio?
Kalbe Farma Tbk PT ADR current P/E ratio is 8.96.
What is Kalbe Farma Tbk PT ADR (PTKFY) EBITDA?
Kalbe Farma Tbk PT ADR EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 77.72 million.
Does Kalbe Farma Tbk PT ADR (PTKFY) pay dividends?
Yes. Kalbe Farma Tbk PT ADR pays annual dividends with an annualized yield of 2.81% and an estimated annual payout of $0.22 per share.
When is the next ex-dividend date for Kalbe Farma Tbk PT ADR (PTKFY)?
The next ex-dividend date is scheduled for June 05, 2027.
What is Kalbe Farma Tbk PT ADR (PTKFY) beta (volatility) score?
Kalbe Farma Tbk PT ADR has a beta of -0.071, indicating lower volatility than the overall market.
